Skip to Main Content
Newsroom
Get in Touch
LinkedIn
Editas Medicine Linkedin
Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors
Newsroom
Get in Touch
LinkedIn
Purchasing Policy Terms and Conditions
+
-
Editas Newsroom
Feb
25
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
Feb
18
Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update
Feb
8
Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer